Class information for:
Level 1: UL97//GANCICLOVIR RESISTANCE//MARIBAVIR

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
15771 692 35.3 86%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
220 3       CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY 50388
429 2             CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HUMAN HERPESVIRUS 6 16394
15771 1                   UL97//GANCICLOVIR RESISTANCE//MARIBAVIR 692

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UL97 authKW 748418 3% 81% 21
2 GANCICLOVIR RESISTANCE authKW 549853 3% 69% 18
3 MARIBAVIR authKW 431646 2% 65% 15
4 ALKYLATION ELIMINATION authKW 313775 1% 89% 8
5 CHEMEXPT CLIN CHEMOTHER Y PROGRAM address 308874 1% 100% 7
6 UL54 authKW 266946 2% 55% 11
7 LETERMOVIR authKW 226926 1% 86% 6
8 METHYLENECYCLOPROPANE ANALOGUES authKW 220625 1% 100% 5
9 HUMAN CYTOMEGALOVIRUS authKW 202796 9% 8% 59
10 REFERENCE CYTOMEGALOVIRUS address 201707 1% 57% 8

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Virology 17590 38% 0% 265
2 Microbiology 2635 26% 0% 183
3 Infectious Diseases 2180 17% 0% 119
4 Pharmacology & Pharmacy 1460 28% 0% 195
5 Transplantation 636 7% 0% 46
6 Immunology 504 14% 0% 100
7 Chemistry, Medicinal 128 5% 0% 33
8 Biotechnology & Applied Microbiology 81 6% 0% 42
9 Biochemical Research Methods 48 4% 0% 26
10 Hematology 16 2% 0% 16

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CHEMEXPT CLIN CHEMOTHER Y PROGRAM 308874 1% 100% 7
2 REFERENCE CYTOMEGALOVIRUS 201707 1% 57% 8
3 CHEMDEV THER EUT PROGRAM 183852 1% 83% 5
4 REFERENCE CYTOMEGALOVIRUSES 132375 0% 100% 3
5 CLIN MOL VIROL 101477 5% 7% 32
6 ASSOCIE REFERENCE CYTOMEGALOVIRUS 88250 0% 100% 2
7 DEV THER EUT PROGRAM CHEM 88250 0% 100% 2
8 DEV THER EUT PROGRAMBARBARA ANN KARMANOS CANC I 88250 0% 100% 2
9 SOMS BABS 88250 0% 100% 2
10 UP EA 4271 88250 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIVIRAL RESEARCH 45859 9% 2% 60
2 JOURNAL OF CLINICAL VIROLOGY 16129 5% 1% 35
3 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 13146 12% 0% 84
4 TRANSPLANT INFECTIOUS DISEASE 8604 2% 1% 15
5 ANTIVIRAL THERAPY 5279 2% 1% 15
6 REVIEWS IN MEDICAL VIROLOGY 4803 1% 1% 8
7 JOURNAL OF INFECTIOUS DISEASES 3768 6% 0% 39
8 NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2710 2% 0% 17
9 JOURNAL OF VIROLOGY 2199 7% 0% 45
10 JOURNAL OF VIROLOGICAL METHODS 2022 3% 0% 18

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 UL97 748418 3% 81% 21 Search UL97 Search UL97
2 GANCICLOVIR RESISTANCE 549853 3% 69% 18 Search GANCICLOVIR+RESISTANCE Search GANCICLOVIR+RESISTANCE
3 MARIBAVIR 431646 2% 65% 15 Search MARIBAVIR Search MARIBAVIR
4 ALKYLATION ELIMINATION 313775 1% 89% 8 Search ALKYLATION+ELIMINATION Search ALKYLATION+ELIMINATION
5 UL54 266946 2% 55% 11 Search UL54 Search UL54
6 LETERMOVIR 226926 1% 86% 6 Search LETERMOVIR Search LETERMOVIR
7 METHYLENECYCLOPROPANE ANALOGUES 220625 1% 100% 5 Search METHYLENECYCLOPROPANE+ANALOGUES Search METHYLENECYCLOPROPANE+ANALOGUES
8 HUMAN CYTOMEGALOVIRUS 202796 9% 8% 59 Search HUMAN+CYTOMEGALOVIRUS Search HUMAN+CYTOMEGALOVIRUS
9 GANCICLOVIR 198850 10% 7% 66 Search GANCICLOVIR Search GANCICLOVIR
10 CYCLOPROPAVIR 198559 1% 75% 6 Search CYCLOPROPAVIR Search CYCLOPROPAVIR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 LURAIN, NS , CHOU, SW , (2010) ANTIVIRAL DRUG RESISTANCE OF HUMAN CYTOMEGALOVIRUS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 23. ISSUE 4. P. 689-712 140 69% 153
2 CAMPOS, AB , RIBEIRO, J , BOUTOLLEAU, D , SOUSA, H , (2016) HUMAN CYTOMEGALOVIRUS ANTIVIRAL DRUG RESISTANCE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: CURRENT STATE OF THE ART.REVIEWS IN MEDICAL VIROLOGY. VOL. 26. ISSUE 3. P. 161 -182 107 71% 3
3 KOMATSU, TE , PIKIS, A , NAEGER, LK , HARRINGTON, PR , (2014) RESISTANCE OF HUMAN CYTOMEGALOVIRUS TO GANCICLOVIR/VALGANCICLOVIR: A COMPREHENSIVE REVIEW OF PUTATIVE RESISTANCE PATHWAYS.ANTIVIRAL RESEARCH. VOL. 101. ISSUE . P. 12-25 106 64% 16
4 CHOU, SW , (2008) CYTOMEGALOVIRUS UL97 MUTATIONS IN THE ERA OF GANCICLOVIR AND MARIBAVIR.REVIEWS IN MEDICAL VIROLOGY. VOL. 18. ISSUE 4. P. 233-246 82 81% 85
5 GILBERT, C , BOIVIN, G , (2005) HUMAN CYTOMEGALOVIRUS RESISTANCE TO ANTIVIRAL DRUGS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 49. ISSUE 3. P. 873 -883 94 71% 120
6 EL CHAER, F , SHAH, DP , CHEMALY, RF , (2016) HOW I TREAT RESISTANT CYTOMEGALOVIRUS INFECTION IN HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENTS.BLOOD. VOL. 128. ISSUE 23. P. 2624 -2636 95 57% 0
7 WEBEL, R , HAKKI, M , PRICHARD, MN , RAWLINSON, WD , MARSCHALL, M , CHOU, SW , (2014) DIFFERENTIAL PROPERTIES OF CYTOMEGALOVIRUS PUL97 KINASE ISOFORMS AFFECT VIRAL REPLICATION AND MARIBAVIR SUSCEPTIBILITY.JOURNAL OF VIROLOGY. VOL. 88. ISSUE 9. P. 4776-4785 51 88% 8
8 BOMMER, M , MICHEL, D , (2013) PREVENTION OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH IMPAIRED CELL-MEDIATED IMMUNITY - IS THERE A NEED FOR MARIBAVIR?.EXPERT OPINION ON ORPHAN DRUGS. VOL. 1. ISSUE 10. P. 829 -836 49 86% 0
9 CHEVILLOTTE, M , VON EINEM, J , MEIER, BM , LIN, FM , KESTLER, HA , MERTENS, T , (2010) A NEW TOOL LINKING HUMAN CYTOMEGALOVIRUS DRUG RESISTANCE MUTATIONS TO RESISTANCE PHENOTYPES.ANTIVIRAL RESEARCH. VOL. 85. ISSUE 2. P. 318-327 57 70% 28
10 PRICHARD, MN , (2009) FUNCTION OF HUMAN CYTOMEGALOVIRUS UL97 KINASE IN VIRAL INFECTION AND ITS INHIBITION BY MARIBAVIR.REVIEWS IN MEDICAL VIROLOGY. VOL. 19. ISSUE 4. P. 215-229 69 49% 52

Classes with closest relation at Level 1


Rank Class id link
1 405 CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY
2 5259 CYTOMEGALOVIRUS RETINITIS//CMV RETINITIS//RETINITIS
3 5066 ACYCLOVIR//ACYCLOVIR RESISTANCE//HERPES SIMPLEX VIRUS
4 6204 US3//VIROL SHOWA KU//JOURNAL OF VIROLOGY
5 786 HUMAN CYTOMEGALOVIRUS//HCMV//VIROLOGY
6 10470 ACYCLIC NUCLEOSIDE PHOSPHONATES//PMEA//CIDOFOVIR
7 13160 ICP8//UL9//ALKALINE NUCLEASE
8 5022 GUINEA PIG CYTOMEGALOVIRUS//CYTOMEGALOVIRUS//MURINE CYTOMEGALOVIRUS
9 10855 BZLF1//BRLF1//LYTIC CYCLE
10 13094 POLYMETHYLENE ANALOGUES//TRICYCLIC ANALOGUES//ACYCLONUCLEOSIDES

Go to start page